Insights On Trial Design

  1. The Power Of Immunotherapy And Precision Medicine In Cancer Research 3/17/2025

    Learn about the key criteria that sponsors should evaluate when selecting a partner for your IO trials to help them improve efficiency, and accelerate the development of life-saving cancer treatments.

  2. How AI Is Shaping The Creation Of 'Regulatory-Grade' Real-World Data 5/20/2025

    Regulatory agencies such as the U.S. FDA and the EMA are increasingly recognizing the value of real-world data (RWD) in shaping clinical research and informing regulatory decisions.

  3. Why Bioanalysis Needs To Break Free From Manual Bottlenecks 9/2/2025

    Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.

  4. Study Start-Up Challenges: Hard Realities, Effective Strategies 3/13/2024

    Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?

  5. Advancing Dose Escalation Strategies With Bayesian Modeling 8/12/2025

    A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.

  6. 3 Strategies For Increasing Diversity In Psychedelic Research 11/13/2023

    Psychedelic research has about 18.4% total minority participation—less than half of the average 38.2% country-level representation. Increase racial and ethnic diversity with these three proven strategies.

  7. 3 Reasons Optimized Trials Are Ideal For Pulmonary Research 7/18/2024

    Formulating studies to better meet the needs of patients is crucial for optimizing its success. This is especially important for complex trials, such as those focused on pulmonary and respiratory conditions.

  8. Psychedelics As Therapeutics – What Developers Need To Know 10/29/2023

    Drug developers and others intrigued by the dynamic and promising field of psychedelics as therapeutics can gain valuable guidance from a recap of the 3rd annual Psychedelic Therapeutic and Drug Development Conference.

  9. Why Engagement Matters In Clinical Trial 5/21/2025

    Here we explore the concept of "patient activation," which empowers individuals to take an active role in their healthcare decisions.

  10. Pathway To Success: How De-Risking Life Sciences Companies Leads To Investment Growth 3/7/2025

    De-risking in clinical development is essential to optimizing trial success and ensuring regulatory approval and strategic decision-making at critical points in a study’s lifecycle can minimize uncertainties.